- Details
- Urologic Oncologist, Deborah Kaye joins Ashish Kamat in a conversation on financial toxicity among bladder cancer patients highlighting the costs of bladder cancer, what is financial toxicity, and lastly, some of the research done on financial toxicity in bladder cancer. Biographies: Deborah Kaye, MD, MS, Urologic Oncologist, Assistant Professor of Surgery, Division of Urology, Duke Cancer Center,...
|
- Details
- In a conversation with Alicia Morgans, Daniel Roberts discusses his innovative approach to oncology care through an academic-community hybrid model. Published in the Journal of Clinical Oncology, this model aims to bridge the gap between academic research and community-based care. Roberts, who is also based at Dana-Farber, explains that the model allows him to engage in clinical medicine while als...
|
- Details
- Lydia Makaroff, Stephanie Chisolm, and Alex Filicevas join Ashish Kamat on UroToday's Bladder Cancer Center of Excellence for a round table discussion on the importance of bladder cancer from a patient perspective and recent efforts by The World Bladder Cancer Patient Coalition. Their recently launched evidence generation study, or bladder cancer patient survey, aims to capture bladder cancer pati...
|
- Details
- As part of this patient-centered video series of lectures on prostate cancer diagnosis and treatment, Dr Sethi presents the timing for radium-223 treatment in mCRPC. She details who qualifies as a candidate for radium 223 therapy, how it is given, the limited side effects of this treatment, that PSA is not a biomarker for treatment success and other treatment management considerations. Biography:...
|
- Details
- Bennett Chin discusses Lutetium-177 PSMA, an investigational class of targeted, radionuclide agents. The focus of this treatment is on Prostate-Specific Membrane Antigen (PSMA), a molecule overexpressed on higher-grade prostate cancer cells. Lutetium-177 is a radioactive beta emitter that binds to PSMA, delivering highly targeted radiation therapy to prostate cancer cells. This emitter also has mi...
|
- Details
- Scott Petinga, a testicular cancer survivor, patient advocate, and entrepreneur, joins Charles Ryan, MD, to provide an update on his work in the field of testicular cancer advocacy. Scott Petinga shares research advances he is a part of at USC as well as different patient resource avenues like social media groups and online forums for newly diagnosed patients and testicular cancer survivors. Biogr...
|
- Details
- In this educational video from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Dr Bital Savir-Baruch, a nuclear medicine physician from Loyola University Medical Center, covers the limitation of conventional imaging for localized prostate cancer sites in patients with suspected disease recurrence, and the role of fluciclovine PET CT imaging in prostate cancer recurrence. Biographies...
|
- Details
- In this patient-focused educational video, Ephraim Parent shares knowledge with patients on the role of skeletal imaging in prostate cancer. Dr. Parent covers the common ways imaging sans are done and, importantly how your physician applies this information to the treatment of metastatic prostate cancer. This video is provided by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Prosta...
|
- Details
- In this UroToday Journal Club, Christopher Wallis and Zachary Klaassen discuss an analysis of risk, racial disparity, and outcomes among United States patients with cancer and COVID-19 infections. In this case-control study, patients with cancer were at significantly increased risk for COVID-19 infection, which was further exacerbated among African Americans, highlighting the need to protect and m...
|
- Details
- In this special patient-centered educational video from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Robert Flavell, an Assistant Professor and the Chief of Molecular Imaging and Therapeutics at the University of California in San Francisco presents on PSMA PET imaging. Dr. Flavell's lecture focuses on how PSMA PET is used in diagnosing prostate cancer and presents a case study o...
|
